APO Research

APO RESEARCH · REPORT

One-Stop Service for Gene-Edited Cell Lines

Selected research

Industry Research

One-Stop Service for Gene-Edited Cell Lines Industry Research Report 2026

Market perspective

The global One-Stop Service for Gene-Edited Cell Lines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the One-Stop Service for Gene-Edited Cell Lines market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the One-Stop Service for Gene-Edited Cell Lines market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the One-Stop Service for Gene-Edited Cell Lines market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of One-Stop Service for Gene-Edited Cell Lines include Amsbio, Charles River Laboratories, Creative Biogene, Cytiva, Eurofins Genomics, Evotec, GenScript, Horizon Discovery and Lonza, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global One-Stop Service for Gene-Edited Cell Lines market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to One-Stop Service for Gene-Edited Cell Lines.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

One-Stop Service for Gene-Edited Cell Lines Market by Company

Amsbio

Charles River Laboratories

Creative Biogene

Cytiva

Eurofins Genomics

Evotec

GenScript

Horizon Discovery

Lonza

ViroCell Biologics

Sartorius

Synbio Technologies

Takara Bio

Thermo Fisher Scientific

BoyaLife

HEMABIO

BGI Genomics

GenScript Biotech

Shanghai Model Organisms

Vazyme

One-Stop Service for Gene-Edited Cell Lines Segment by Type

Gene Knockout Service

Gene Knockin Service

One-Stop Service for Gene-Edited Cell Lines Segment by Application

Universities and Research Institutions

Biopharmaceutical Industry

Others

One-Stop Service for Gene-Edited Cell Lines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global One-Stop Service for Gene-Edited Cell Lines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of One-Stop Service for Gene-Edited Cell Lines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of One-Stop Service for Gene-Edited Cell Lines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of One-Stop Service for Gene-Edited Cell Lines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global One-Stop Service for Gene-Edited Cell Lines Market Size by Type (2021-2026) & (US$ Million) Table 6. Global One-Stop Service for Gene-Edited Cell Lines Revenue Market Share by Type (2021-2026) Table 7. Global One-Stop Service for Gene-Edited Cell Lines Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global One-Stop Service for Gene-Edited Cell Lines Revenue Market Share by Type (2027-2032) Table 9. Global One-Stop Service for Gene-Edited Cell Lines Market Size by Application (2021-2026) & (US$ Million) Table 10. Global One-Stop Service for Gene-Edited Cell Lines Revenue Market Share by Application (2021-2026) Table 11. Global One-Stop Service for Gene-Edited Cell Lines Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global One-Stop Service for Gene-Edited Cell Lines Revenue Market Share by Application (2027-2032) Table 13. Global One-Stop Service for Gene-Edited Cell Lines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global One-Stop Service for Gene-Edited Cell Lines Market Size by Region (2021-2026) & (US$ Million) Table 15. Global One-Stop Service for Gene-Edited Cell Lines Market Share by Region (2021-2026) Table 16. Global One-Stop Service for Gene-Edited Cell Lines Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global One-Stop Service for Gene-Edited Cell Lines Market Share by Region (2027-2032) Table 18. One-Stop Service for Gene-Edited Cell Lines Industry Trends Table 19. One-Stop Service for Gene-Edited Cell Lines Industry Drivers Table 20. One-Stop Service for Gene-Edited Cell Lines Industry Opportunities and Challenges Table 21. One-Stop Service for Gene-Edited Cell Lines Market Restraints Table 22. Global Top One-Stop Service for Gene-Edited Cell Lines Players by Revenue (US$ Million) & (2021-2026) Table 23. Global One-Stop Service for Gene-Edited Cell Lines Revenue Market Share by Players (2021-2026) Table 24. Global One-Stop Service for Gene-Edited Cell Lines Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of One-Stop Service for Gene-Edited Cell Lines, Headquarters and Area Served Table 26. Global One-Stop Service for Gene-Edited Cell Lines Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global One-Stop Service for Gene-Edited Cell Lines by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America One-Stop Service for Gene-Edited Cell Lines Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2021-2026) & (US$ Million) Table 32. North America One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe One-Stop Service for Gene-Edited Cell Lines Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific One-Stop Service for Gene-Edited Cell Lines Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific One-Stop Service for Gene-Edited Cell Lines Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2027-2032) & (US$ Million) Table 39. South America One-Stop Service for Gene-Edited Cell Lines Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2021-2026) & (US$ Million) Table 41. South America One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2027-2032) & (US$ Million) Table 45. Amsbio Company Information Table 46. Amsbio Business Overview Table 47. Amsbio Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) & (US$ Million) Table 48. Amsbio One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 49. Amsbio Recent Developments Table 50. Charles River Laboratories Company Information Table 51. Charles River Laboratories Business Overview Table 52. Charles River Laboratories Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) & (US$ Million) Table 53. Charles River Laboratories One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 54. Charles River Laboratories Recent Developments Table 55. Creative Biogene Company Information Table 56. Creative Biogene Business Overview Table 57. Creative Biogene Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) & (US$ Million) Table 58. Creative Biogene One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 59. Creative Biogene Recent Developments Table 60. Cytiva Company Information Table 61. Cytiva Business Overview Table 62. Cytiva Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) & (US$ Million) Table 63. Cytiva One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 64. Cytiva Recent Developments Table 65. Eurofins Genomics Company Information Table 66. Eurofins Genomics Business Overview Table 67. Eurofins Genomics Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) & (US$ Million) Table 68. Eurofins Genomics One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 69. Eurofins Genomics Recent Developments Table 70. Evotec Company Information Table 71. Evotec Business Overview Table 72. Evotec Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) & (US$ Million) Table 73. Evotec One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 74. Evotec Recent Developments Table 75. GenScript Company Information Table 76. GenScript Business Overview Table 77. GenScript Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) & (US$ Million) Table 78. GenScript One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 79. GenScript Recent Developments Table 80. Horizon Discovery Company Information Table 81. Horizon Discovery Business Overview Table 82. Horizon Discovery Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) & (US$ Million) Table 83. Horizon Discovery One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 84. Horizon Discovery Recent Developments Table 85. Lonza Company Information Table 86. Lonza Business Overview Table 87. Lonza Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) & (US$ Million) Table 88. Lonza One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 89. Lonza Recent Developments Table 90. ViroCell Biologics Company Information Table 91. ViroCell Biologics Business Overview Table 92. ViroCell Biologics Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) & (US$ Million) Table 93. ViroCell Biologics One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 94. ViroCell Biologics Recent Developments Table 95. Sartorius Company Information Table 96. Sartorius Business Overview Table 97. Sartorius Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) & (US$ Million) Table 98. Sartorius One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 99. Sartorius Recent Developments Table 100. Synbio Technologies Company Information Table 101. Synbio Technologies Business Overview Table 102. Synbio Technologies Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) & (US$ Million) Table 103. Synbio Technologies One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 104. Synbio Technologies Recent Developments Table 105. Takara Bio Company Information Table 106. Takara Bio Business Overview Table 107. Takara Bio Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) & (US$ Million) Table 108. Takara Bio One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 109. Takara Bio Recent Developments Table 110. Thermo Fisher Scientific Company Information Table 111. Thermo Fisher Scientific Business Overview Table 112. Thermo Fisher Scientific Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) & (US$ Million) Table 113. Thermo Fisher Scientific One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 114. Thermo Fisher Scientific Recent Developments Table 115. BoyaLife Company Information Table 116. BoyaLife Business Overview Table 117. BoyaLife Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) & (US$ Million) Table 118. BoyaLife One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 119. BoyaLife Recent Developments Table 120. HEMABIO Company Information Table 121. HEMABIO Business Overview Table 122. HEMABIO Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) & (US$ Million) Table 123. HEMABIO One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 124. HEMABIO Recent Developments Table 125. BGI Genomics Company Information Table 126. BGI Genomics Business Overview Table 127. BGI Genomics Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) & (US$ Million) Table 128. BGI Genomics One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 129. BGI Genomics Recent Developments Table 130. GenScript Biotech Company Information Table 131. GenScript Biotech Business Overview Table 132. GenScript Biotech Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) & (US$ Million) Table 133. GenScript Biotech One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 134. GenScript Biotech Recent Developments Table 135. Shanghai Model Organisms Company Information Table 136. Shanghai Model Organisms Business Overview Table 137. Shanghai Model Organisms Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) & (US$ Million) Table 138. Shanghai Model Organisms One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 139. Shanghai Model Organisms Recent Developments Table 140. Vazyme Company Information Table 141. Vazyme Business Overview Table 142. Vazyme Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) & (US$ Million) Table 143. Vazyme One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 144. Vazyme Recent Developments Table 145. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. One-Stop Service for Gene-Edited Cell Lines Product Image Figure 5. Global One-Stop Service for Gene-Edited Cell Lines Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global One-Stop Service for Gene-Edited Cell Lines Market Share by Type: 2025 VS 2032 Figure 7. Gene Knockout Service Product Figure 8. Gene Knockin Service Product Figure 9. Global One-Stop Service for Gene-Edited Cell Lines Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global One-Stop Service for Gene-Edited Cell Lines Market Share by Application: 2025 VS 2032 Figure 11. Universities and Research Institutions Product Figure 12. Biopharmaceutical Industry Product Figure 13. Others Product Figure 14. Global One-Stop Service for Gene-Edited Cell Lines Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 15. Global One-Stop Service for Gene-Edited Cell Lines Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global One-Stop Service for Gene-Edited Cell Lines Market Share by Region: 2025 VS 2032 Figure 17. Global One-Stop Service for Gene-Edited Cell Lines Market Share by Players in 2025 Figure 18. Global One-Stop Service for Gene-Edited Cell Lines Manufacturers Established Date Figure 19. Global Top 5 and 10 One-Stop Service for Gene-Edited Cell Lines Players Market Share by Revenue in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. North America One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. North America One-Stop Service for Gene-Edited Cell Lines Market Share by Country (2021-2032) Figure 23. United States One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Canada One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Mexico One-Stop Service for Gene-Edited Cell Lines Market Share by Country (2021-2032) Figure 26. Europe One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Europe One-Stop Service for Gene-Edited Cell Lines Market Share by Country (2021-2032) Figure 28. Germany One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. France One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. U.K. One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Italy One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Spain One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Russia One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Netherlands One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Nordic Countries One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Asia-Pacific One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific One-Stop Service for Gene-Edited Cell Lines Market Share by Country (2021-2032) Figure 38. China One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Japan One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. South Korea One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. India One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India One-Stop Service for Gene-Edited Cell Lines Market Share by Country (2021-2032) Figure 43. Australia One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. China Taiwan One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. Southeast Asia One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. South America One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America One-Stop Service for Gene-Edited Cell Lines Market Share by Country (2021-2032) Figure 48. Brazil One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. Argentina One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Chile One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Colombia One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Peru One-Stop Service for Gene-Edited Cell Lines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Amsbio Revenue Growth Rate in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) Figure 54. Charles River Laboratories Revenue Growth Rate in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) Figure 55. Creative Biogene Revenue Growth Rate in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) Figure 56. Cytiva Revenue Growth Rate in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) Figure 57. Eurofins Genomics Revenue Growth Rate in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) Figure 58. Evotec Revenue Growth Rate in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) Figure 59. GenScript Revenue Growth Rate in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) Figure 60. Horizon Discovery Revenue Growth Rate in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) Figure 61. Lonza Revenue Growth Rate in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) Figure 62. ViroCell Biologics Revenue Growth Rate in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) Figure 63. Sartorius Revenue Growth Rate in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) Figure 64. Synbio Technologies Revenue Growth Rate in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) Figure 65. Takara Bio Revenue Growth Rate in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) Figure 66. Thermo Fisher Scientific Revenue Growth Rate in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) Figure 67. BoyaLife Revenue Growth Rate in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) Figure 68. HEMABIO Revenue Growth Rate in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) Figure 69. BGI Genomics Revenue Growth Rate in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) Figure 70. GenScript Biotech Revenue Growth Rate in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) Figure 71. Shanghai Model Organisms Revenue Growth Rate in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026) Figure 72. Vazyme Revenue Growth Rate in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)

Scope & coverage.

Types
  • Gene Knockout Service
  • Gene Knockin Service
Applications
  • Universities and Research Institutions
  • Biopharmaceutical Industry
  • Others
Companies covered
  • Amsbio
  • Charles River Laboratories
  • Creative Biogene
  • Cytiva
  • Eurofins Genomics
  • Evotec
  • GenScript
  • Horizon Discovery
  • Lonza
  • ViroCell Biologics
  • Sartorius
  • Synbio Technologies
  • Takara Bio
  • Thermo Fisher Scientific
  • BoyaLife
  • HEMABIO
  • BGI Genomics
  • GenScript Biotech
  • Shanghai Model Organisms
  • Vazyme

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 One-Stop Service for Gene-Edited Cell Lines by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Gene Knockout Service
  5. 2.2.3 Gene Knockin Service
  6. 2.3 One-Stop Service for Gene-Edited Cell Lines by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Universities and Research Institutions
  9. 2.3.3 Biopharmaceutical Industry
  10. 2.3.4 Others
  11. 2.4 Assumptions and Limitations
3 One-Stop Service for Gene-Edited Cell Lines Breakdown Data by Type
  1. 3.1 Global One-Stop Service for Gene-Edited Cell Lines Historic Market Size by Type (2021-2026)
  2. 3.2 Global One-Stop Service for Gene-Edited Cell Lines Forecasted Market Size by Type (2027-2032)
4 One-Stop Service for Gene-Edited Cell Lines Breakdown Data by Application
  1. 4.1 Global One-Stop Service for Gene-Edited Cell Lines Historic Market Size by Application (2021-2026)
  2. 4.2 Global One-Stop Service for Gene-Edited Cell Lines Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global One-Stop Service for Gene-Edited Cell Lines Market Perspective (2021-2032)
  2. 5.2 Global One-Stop Service for Gene-Edited Cell Lines Growth Trends by Region
  3. 5.2.1 Global One-Stop Service for Gene-Edited Cell Lines Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 One-Stop Service for Gene-Edited Cell Lines Historic Market Size by Region (2021-2026)
  5. 5.2.3 One-Stop Service for Gene-Edited Cell Lines Forecasted Market Size by Region (2027-2032)
  6. 5.3 One-Stop Service for Gene-Edited Cell Lines Market Dynamics
  7. 5.3.1 One-Stop Service for Gene-Edited Cell Lines Industry Trends
  8. 5.3.2 One-Stop Service for Gene-Edited Cell Lines Market Drivers
  9. 5.3.3 One-Stop Service for Gene-Edited Cell Lines Market Challenges
  10. 5.3.4 One-Stop Service for Gene-Edited Cell Lines Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top One-Stop Service for Gene-Edited Cell Lines Players by Revenue
  2. 6.1.1 Global Top One-Stop Service for Gene-Edited Cell Lines Players by Revenue (2021-2026)
  3. 6.1.2 Global One-Stop Service for Gene-Edited Cell Lines Revenue Market Share by Players (2021-2026)
  4. 6.2 Global One-Stop Service for Gene-Edited Cell Lines Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of One-Stop Service for Gene-Edited Cell Lines Head Office and Area Served
  6. 6.4 Global One-Stop Service for Gene-Edited Cell Lines Players, Product Type & Application
  7. 6.5 Global One-Stop Service for Gene-Edited Cell Lines Manufacturers Established Date
  8. 6.6 Global One-Stop Service for Gene-Edited Cell Lines Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America One-Stop Service for Gene-Edited Cell Lines Market Size (2021-2032)
  2. 7.2 North America One-Stop Service for Gene-Edited Cell Lines Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2021-2026)
  4. 7.4 North America One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe One-Stop Service for Gene-Edited Cell Lines Market Size (2021-2032)
  2. 8.2 Europe One-Stop Service for Gene-Edited Cell Lines Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2021-2026)
  4. 8.4 Europe One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific One-Stop Service for Gene-Edited Cell Lines Market Size (2021-2032)
  2. 9.2 Asia-Pacific One-Stop Service for Gene-Edited Cell Lines Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America One-Stop Service for Gene-Edited Cell Lines Market Size (2021-2032)
  2. 10.2 South America One-Stop Service for Gene-Edited Cell Lines Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2021-2026)
  4. 10.4 South America One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Market Size (2021-2032)
  2. 11.2 Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Amsbio
  2. 12.1.1 Amsbio Company Information
  3. 12.1.2 Amsbio Business Overview
  4. 12.1.3 Amsbio Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
  5. 12.1.4 Amsbio One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  6. 12.1.5 Amsbio Recent Developments
  7. 12.2 Charles River Laboratories
  8. 12.2.1 Charles River Laboratories Company Information
  9. 12.2.2 Charles River Laboratories Business Overview
  10. 12.2.3 Charles River Laboratories Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
  11. 12.2.4 Charles River Laboratories One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  12. 12.2.5 Charles River Laboratories Recent Developments
  13. 12.3 Creative Biogene
  14. 12.3.1 Creative Biogene Company Information
  15. 12.3.2 Creative Biogene Business Overview
  16. 12.3.3 Creative Biogene Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
  17. 12.3.4 Creative Biogene One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  18. 12.3.5 Creative Biogene Recent Developments
  19. 12.4 Cytiva
  20. 12.4.1 Cytiva Company Information
  21. 12.4.2 Cytiva Business Overview
  22. 12.4.3 Cytiva Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
  23. 12.4.4 Cytiva One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  24. 12.4.5 Cytiva Recent Developments
  25. 12.5 Eurofins Genomics
  26. 12.5.1 Eurofins Genomics Company Information
  27. 12.5.2 Eurofins Genomics Business Overview
  28. 12.5.3 Eurofins Genomics Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
  29. 12.5.4 Eurofins Genomics One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  30. 12.5.5 Eurofins Genomics Recent Developments
  31. 12.6 Evotec
  32. 12.6.1 Evotec Company Information
  33. 12.6.2 Evotec Business Overview
  34. 12.6.3 Evotec Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
  35. 12.6.4 Evotec One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  36. 12.6.5 Evotec Recent Developments
  37. 12.7 GenScript
  38. 12.7.1 GenScript Company Information
  39. 12.7.2 GenScript Business Overview
  40. 12.7.3 GenScript Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
  41. 12.7.4 GenScript One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  42. 12.7.5 GenScript Recent Developments
  43. 12.8 Horizon Discovery
  44. 12.8.1 Horizon Discovery Company Information
  45. 12.8.2 Horizon Discovery Business Overview
  46. 12.8.3 Horizon Discovery Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
  47. 12.8.4 Horizon Discovery One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  48. 12.8.5 Horizon Discovery Recent Developments
  49. 12.9 Lonza
  50. 12.9.1 Lonza Company Information
  51. 12.9.2 Lonza Business Overview
  52. 12.9.3 Lonza Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
  53. 12.9.4 Lonza One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  54. 12.9.5 Lonza Recent Developments
  55. 12.10 ViroCell Biologics
  56. 12.10.1 ViroCell Biologics Company Information
  57. 12.10.2 ViroCell Biologics Business Overview
  58. 12.10.3 ViroCell Biologics Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
  59. 12.10.4 ViroCell Biologics One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  60. 12.10.5 ViroCell Biologics Recent Developments
  61. 12.11 Sartorius
  62. 12.11.1 Sartorius Company Information
  63. 12.11.2 Sartorius Business Overview
  64. 12.11.3 Sartorius Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
  65. 12.11.4 Sartorius One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  66. 12.11.5 Sartorius Recent Developments
  67. 12.12 Synbio Technologies
  68. 12.12.1 Synbio Technologies Company Information
  69. 12.12.2 Synbio Technologies Business Overview
  70. 12.12.3 Synbio Technologies Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
  71. 12.12.4 Synbio Technologies One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  72. 12.12.5 Synbio Technologies Recent Developments
  73. 12.13 Takara Bio
  74. 12.13.1 Takara Bio Company Information
  75. 12.13.2 Takara Bio Business Overview
  76. 12.13.3 Takara Bio Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
  77. 12.13.4 Takara Bio One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  78. 12.13.5 Takara Bio Recent Developments
  79. 12.14 Thermo Fisher Scientific
  80. 12.14.1 Thermo Fisher Scientific Company Information
  81. 12.14.2 Thermo Fisher Scientific Business Overview
  82. 12.14.3 Thermo Fisher Scientific Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
  83. 12.14.4 Thermo Fisher Scientific One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  84. 12.14.5 Thermo Fisher Scientific Recent Developments
  85. 12.15 BoyaLife
  86. 12.15.1 BoyaLife Company Information
  87. 12.15.2 BoyaLife Business Overview
  88. 12.15.3 BoyaLife Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
  89. 12.15.4 BoyaLife One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  90. 12.15.5 BoyaLife Recent Developments
  91. 12.16 HEMABIO
  92. 12.16.1 HEMABIO Company Information
  93. 12.16.2 HEMABIO Business Overview
  94. 12.16.3 HEMABIO Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
  95. 12.16.4 HEMABIO One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  96. 12.16.5 HEMABIO Recent Developments
  97. 12.17 BGI Genomics
  98. 12.17.1 BGI Genomics Company Information
  99. 12.17.2 BGI Genomics Business Overview
  100. 12.17.3 BGI Genomics Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
  101. 12.17.4 BGI Genomics One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  102. 12.17.5 BGI Genomics Recent Developments
  103. 12.18 GenScript Biotech
  104. 12.18.1 GenScript Biotech Company Information
  105. 12.18.2 GenScript Biotech Business Overview
  106. 12.18.3 GenScript Biotech Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
  107. 12.18.4 GenScript Biotech One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  108. 12.18.5 GenScript Biotech Recent Developments
  109. 12.19 Shanghai Model Organisms
  110. 12.19.1 Shanghai Model Organisms Company Information
  111. 12.19.2 Shanghai Model Organisms Business Overview
  112. 12.19.3 Shanghai Model Organisms Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
  113. 12.19.4 Shanghai Model Organisms One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  114. 12.19.5 Shanghai Model Organisms Recent Developments
  115. 12.20 Vazyme
  116. 12.20.1 Vazyme Company Information
  117. 12.20.2 Vazyme Business Overview
  118. 12.20.3 Vazyme Revenue in One-Stop Service for Gene-Edited Cell Lines Business (2021-2026)
  119. 12.20.4 Vazyme One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  120. 12.20.5 Vazyme Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research